10 Stocks Under $10 that Will Triple
As we delve into the discussion on stocks that will triple, we must shed light on the U.S.
Day One Biopharmaceuticals Inc. (DAWN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 5,755,577 | $72,923,161 | -27% | 0.97% |
| 2. | Braidwell LP Alex Karnal | 4,873,853 | $61,751,718 | 1.83% | |
| 3. | Estuary Capital Andrew Warford | 3,716,777 | $47,091,565 | +36% | 13.75% |
| 4. | Deerfield Management James E. Flynn | 2,596,033 | $32,891,738 | -1% | 0.62% |
| 5. | Alyeska Investment Group Anand Parekh | 2,512,187 | $31,829,409 | 0.11% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.97 | 111,387 | Large Shareholder | 12,929,322 | 2023-10-20 | Filing | |
| $10.06 | 384,400 | Large Shareholder | 12,817,935 | 2023-10-19 | Filing | |
| $10.21 | 979,667 | Large Shareholder | 12,433,535 | 2023-10-18 | Filing | |
| $13.00 | 769,230 | Large Shareholder | 11,453,868 | 2023-06-09 | Filing | |
| $15.00 | 766,667 | Large Shareholder | 766,667 | 2022-06-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.96 | 4,370 | 252,638 | 2025-02-18 | Filing | ||
| $11.96 | 4,646 | 39,602 | 2025-02-18 | Filing | ||
| $11.96 | 12,048 | 128,015 | 2025-02-18 | Filing | ||
| $13.31 | 30,000 | 1,034,015 | 2024-12-10 | Filing | ||
| $13.21 | 10,554 | 108,377 | 2024-11-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 137,968 | $1,094,086 | 0.05% | |
| 2. | 81,844 | $649,010 | 0% | |
| 3. | 14,693 | $116,515 | 0% | |
| 4. | 11,154 | $88,452 | 0% | |
| 5. | 11,005 | $87,270 | 0% |
News See All
Day One Biopharmaceuticals, Inc. (DAWN): A Bull Case Theory
We came across a bullish thesis on Day One Biopharmaceuticals, Inc. (DAWN) on Twitter by Pharmdca. In this article, we will summarize the bulls’ thesis on DAWN. Day One Biopharmaceuticals, Inc.
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Q4 2024 Earnings Call Transcript
Operator: Hello, ladies and gentlemen, and welcome to the Day One Biopharmaceuticals Fourth Quarter and Full Year 2024 Financial and Operating Results Conference Call.
Billionaire Andreas Halvorsen's Top 15 Long-Term Stock Picks
Andreas Halvorsen is a prominent Norwegian hedge fund manager and the co-founder of Viking Global, one of the most successful equity-focused hedge funds in the world.
10 Best Up and Coming Stocks To Buy According to Analysts
Donald Trump's victory in the recent presidential election is expected to encourage companies that have been hesitant to pursue IPOs in 2025, capitalizing on the positive market reaction and anticipated...
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Q3 2024 Earnings Call Transcript
Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) Q3 2024 Earnings Call Transcript October 30, 2024Day One Biopharmaceuticals, Inc. beats earnings expectations.
10 Biggest Stocks with Negative Beta to Consider
Beta is a measurement of market risk or volatility that indicates how much the price of a stock tends to fluctuate up and down compared to other stocks.
13 Best Biotech Stocks To Buy Under $20
In this article, we're going to take a look at 13 best biotech stocks to buy under $20.
12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds
In this article we present the list of 12 Best Small-Cap Biotech Stocks with Massive Potential According to Hedge Funds.
25 Biggest Stocks with Negative Beta
Stock markets were in see-saw mode before the Fed’s September decision on rate hikes.
Billionaire Hedge Funds
